Jason Rosenstock
🏛️ Revolving DoorFormer Government Positions:
Legislative Counsel, Rep. Tom Lantos; Intern, Rep. Robert Weygand
Leg. Counsel, Rep. Tom Lantos; Intern, Rep. Robert Weygand
Legislative Counsel, Rep. Tom Lantos
Leg. Counsel, Rep. Tom Lantos
🤖
AI Overview
Jason Rosenstock has appeared in 1,056 federal lobbying filings at Thorn Run Partners, representing 33 clients. As a former government official, they bring insider expertise to their lobbying work — part of Washington's "revolving door." Active across 26 policy areas.
1,056
Total Filings
1
Firms
33
Clients
26
Issue Areas
Issue Areas
Filing History
| Year | Filings | Clients |
|---|---|---|
| 2018 | 73 | 14 |
| 2019 | 102 | 16 |
| 2020 | 134 | 18 |
| 2021 | 152 | 23 |
| 2022 | 158 | 23 |
| 2023 | 157 | 22 |
| 2024 | 160 | 23 |
| 2025 | 120 | 21 |
Firms
Thorn Run Partners1056 filings
Top Clients
Ebay INC85 filings
Equifax INC.79 filings
Jm Family Enterprises, INC70 filings
Tripadvisor LLC68 filings
Jackson National Life Insurance Company62 filings
Encore Capital Group57 filings
Paypal51 filings
Allstate Insurance Company49 filings
Ernst & Young U.S. LLP (EY)48 filings
Pathward, N.a.42 filings
Fluor Corporation41 filings
Onemain Financial Group, LLC37 filings
Interdigital, INC.30 filings
Incomm Holdings, INC.28 filings
T-mobile USA, INC.28 filings
Comcast Corporation27 filings
Avanci19 filings
Related Analysis
Related Investigations
The Revolving Door Exposed
How former government officials become the most powerful lobbyists.
Follow the Money
Tracking lobbying dollars through the financial system.
The 2025 Tariff Panic
As tariffs return, lobbying on trade surges.
The 22,000% ROI
When lobbying spending yields outsized returns.
Big Tech's $150M Lobbying War
Tech giants battle over AI, antitrust, privacy, and trade.
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.